25th Apr 2008 10:29
Whatman PLC25 April 2008 GE Healthcare completes acquisition of Whatman plc Chalfont St. Giles, UK. 25 April 2008 GE Healthcare, a unit of General Electric Company (NYSE:GE) announced today thatit has completed the acquisition of Whatman plc, a global supplier of filtrationproducts and technologies. The acquisition expands GE Healthcare's offering for life science research andbiopharmaceutical manufacturing, a key area of growth for the company. GEHealthcare's Life Sciences business is a world-class provider of technologiesfor cellular and protein science research, and tools used in the manufacture ofbiopharmaceuticals such as vaccines, cell therapies and antibodies. The additionof Whatman's innovative filters and membranes for laboratory research, lifesciences and medical technology applications will offer substantial customerbenefits and create significant synergies through complementary product andservice offerings. Commenting on the close, Peter Ehrenheim President and CEO of GE Healthcare'sLife Sciences business said "Whatman's expertise and reputation in filtrationtechnologies and sample preparation is a great fit for our Life Sciencesbusiness. We believe that combining the skills of the two companies will enableGE Healthcare to create strong added value for customers in biomedical and drugdiscovery research." About GE Healthcare GE Healthcare provides transformational medical technologies and services thatare shaping a new age of patient care. Our expertise in medical imaging andinformation technologies, medical diagnostics, patient monitoring systems,performance improvement, drug discovery, and biopharmaceutical manufacturingtechnologies is helping clinicians around the world re-imagine new ways topredict, diagnose, inform and treat disease, so their patients can live theirlives to the fullest. GE Healthcare's broad range of products and services enable healthcare providersto better diagnose and treat cancer, heart disease, neurological diseases, andother conditions earlier. Our vision for the future is to enable a new "earlyhealth" model of care focused on earlier diagnosis, pre-symptomatic diseasedetection and disease prevention. Headquartered in the United Kingdom, GEHealthcare is a US$17 billion unit of General Electric Company (NYSE: GE).Worldwide, GE Healthcare employs more than 46,000 people committed to servinghealthcare professionals and their patients in more than 100 countries. For moreinformation about GE Healthcare, visit our website at www.gehealthcare.com. About Whatman A global leader in filtration technology, Whatman provides innovative lifescience products to the scientific community. Whatman has developed total samplepreparation solutions through its robust line of filtration devices andmembranes. The Company's breakthrough protein array technology and FTA(R)Technology to capture archive and purify DNA at room temperature, enables it toprovide novel solutions for the analytical, health care, and bioscience markets.For more information please visit www.whatman.com For media inquiries, please contact: GE Healthcare - InternationalDr Val JonesTel. +44 7917 175 [email protected] Conor McKechnieTel. +44 7717 517 [email protected] GE Healthcare - AmericasBrian McKaigTel. +1 414 477 [email protected] This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
GEC.L